#Christina Schollin

[saturn7887]

Christina Schollin

[motionpicturelover]

"Bröllopsbesvär" (1964) - Åke Falck

Films I've watched in 2023 (116/119)

[tvln]

käre john (swe, lindgren 64)

[thatcreepyaesthetic]

Mumindalen 1973 (X)

“Våga bli arg / Dare to be angry”

[ozu-teapot]

Fanny och Alexander (Fanny and Alexander) | Ingmar Bergman | 1982

The Second Act: The Ghost (AKA The Ghost Rehearsal)

[junkielee]

[Film Review] Fanny and Alexander (1982)

English Title: Fanny and Alexander Original Title: Fanny och Alexander Year: 1982 Country: Swedish, France, West Germany Language: Swedish, German, Yiddish, English, French Genre: Drama Director/Writer: Ingmar Bergman Music: Daniel Bell Cinematography: Sven Nykvist Cast: Bertil Guve Ewa Fröling Jan Malmsjö Gunn Wållgren Jarl Kulle Allan Edwall Börje Ahlstedt Erland Josephson Pernilla Allwin Mona…

[higherentity]

... summer girls

[diabolikdiabolik]

Käre John (Dear John, 1964)

Smoothly hugging a woman and a tree at the same time.

[baalberith-is-here]

christina schollin

[malagaminnen]

Måndag 18/3, del 2

Efter grottbesöket återvände jag till Nerja centrum där jag promenerade runt en stund. Liksom många av städerna längs Costa del Sol är Nerja en turistmagnet, välbelfolkad av pensionerade skandinaver (bland annat Christina Schollin har ett hus i Nerja). Därför var jag inte förvånad att se både svenska mäklarfirmor samt en svensk butik, "Hemlängtan", som bara sålde svenska produkter.

En annan sevärdhet i Nerja, förutom grottorna, är Balcón de Europa, som enligt mig inte var något värt att se överhuvudtaget. Det var typ en liten plattform ut i havet. Jag förstod verkligen inte grejen.

På bilderna ovan ser ni Balcón de Europa med dess utsikt över havet och kusten.

I alla fall. Jag återvände hem till Málaga med trötta ben, ännu mer foton i mobilen och ännu fler trevliga upplevelser i minnet.

[medicalnewsupdates]

Why are Biostatistics Essential for Successful Clinical Trial Management?

The role of biostatisticians goes far beyond analyzing data at the end of a clinical study. Instead, they should be involved in clinical trial management right from the start to maximize the chances for a new drug’s market approval.

Biostatisticians in clinical trial management have a long to-do list. They advise on study design, calculate the right sample size, and ensure that the enrolled patients are correctly randomized. They help define endpoints, provide definitions for data analysis and create tables and figures for the clinical study report.

Malin Schollin, Director of Biostatistics at LINK Medical

“People often think that biostatistics comes in at the end of a clinical trial, but this can lead to a lot of issues, for example, when you find out too late about missing data or incorrect randomization.”

“There is great value in having a statistician on board during the entire project because then we can take part in the decision making, and help assess how it will affect analyses, evaluation, or results,” said Malin Schollin, Director of Biostatistics at LINK Medical, a Swedish contract research organization.

Meaningful data at manageable costs

Christina Ehrenkrona, Senior Biostatistician at LINK Medical

The work of biostatisticians starts with the preparation of the clinical study protocol.

“The clinical study protocol is really the core of any clinical study. We need precise calculations to ensure we enroll the right number of patients – not too many to keep costs manageable, but enough to obtain statistically relevant data,” explained Christina Ehrenkrona, Senior Biostatistician at LINK Medical.

In addition, the clinical study protocol defines the objectives and endpoints to be assessed during the clinical trial. Biostatisticians need to understand the scientific question underlying the study to give input to suitable parameters that can be measured with statistical relevance.

“Sometimes, we do real detective work in order to find the necessary input for the sample size calculation,” said Ehrenkrona. “Together with the clinicians, we research the studies that have been done before for similar treatments and how the data in these previous studies have been collected and analyzed.” 

Gunnar Danielsson, Senior Regulatory Advisor at LINK Medical

Biostatisticians also suggest exploratory endpoints in early phases that might be useful in future studies.

“You often see that the primary endpoint changes between early and late clinical phases to apply the knowledge gained along the way. We provide guidance on what is measurable, analyzable, and clinically relevant,” added Gunnar Danielsson, Senior Regulatory Advisor at LINK Medical. 

Avoiding bias in clinical study data

Another essential task for biostatisticians is to support the randomization and stratification of study participants to avoid bias in the resulting data. Bias can occur when clinical trial results are affected by factors not related to the treatment being tested. 

Stratification of patient subgroups – those receiving either the treatment or placebo – ensures that the subgroups are sufficiently homogeneous to be comparable.

Especially with sites in different countries or environments, it is essential to ensure that subgroups should contain a representative partition of the local population.

“A classic example is the initial association between alcohol consumption and lung cancer – not considering that many people who regularly consume alcohol also smoke a lot. We need the input from clinicians on what might be affecting the treatment to obtain meaningful data on the treatment effect,” Schollin explained.

Biostatistics for successful market authorization

Maybe the most important document that biostatisticians create is the statistical analysis plan. It outlines in detail how the collected data will be used, analyzed, and displayed in tables and figures. 

To pave the way for successful market authorization, the information the biostatisticians prepare for the clinical study report must be both statistically valid and compliant with regulatory requirements.

“The statistical analysis plan is a document that contains all our recipes,” Ehrenkrona explained. “It is finalized and signed before the database is locked and the data unblinded, meaning that we can assign the patients to the treatment groups. If we haven’t prepared our plan carefully, there’s no second chance.”

Clinical trial management is a team effort

Conducting a clinical development program is a team effort that includes input from medical, clinical operations, pharmacovigilance, and regulatory professionals, as well as a continuous involvement of biostatistics and data management experts.

Maintaining the same team throughout different clinical trials increases shared knowledge and allows lessons learned to be taken to the next clinical phase – saving time and cost while increasing the overall quality of the trial, and, ultimately, the chances for successful market authorization. 

“At LINK Medical, our biostatistics team includes professionals with expertise in biostatistics, programming, and senior advisors with knowledge of regulatory requirements, giving our clients the broadest possible knowledge base,” Danielsson concluded.

Read more about how the biostatisticians at LINK Medical can support your clinical trial management! 

Source link

The post Why are Biostatistics Essential for Successful Clinical Trial Management? appeared first on Medical News And Updates.

[love-midnight-sunshine]

Genre: Biography, Drama, Musical, Romance

Language: English

IMDb Ratings: 3.9/10

Quality: BluRay

Movie Size: 720p (1.71GB)

Director: Andrew L. Stone

Movie Cast: Florence Henderson, Toralv Maurstad, Christina Schollin

Download Here -      (1080p Coming Soon)

Sypnosis: Based on the life of Norway's greatest composer Edvard Grieg, and filmed in Norway where he lived. The soundtrack is all Edvard Grieg's music with added lyrics.

Note - Report Dead Or Broken Link With URL 'HERE' (Links Will ReUp Soon) Watch Trailer

Screenshot

[motionpicturelover]

"Änglar, finns dom?" (1962) - Lars-Magnus Lindgren

"February Film Favourites" Day 27/28

[cawamedia]

Invitation to celebrate the 100th anniversary of Ingmar Bergman’s birth with us!

On July 14, 1918, Ernst Ingmar Bergman was born in Uppsala and the centennial anniversary of his memory is celebrated throughout 2018 worldwide.

Saturday, July 14, at 19.00 at The Performing Arts Museum, Sibyllegatan 2, Stockholm Drinks and light snacks are served during the evening.

A selection of guests attending:

Christina Schollin

Stina Ekblad

Ann-Margret Pettersson

Ingrid Dahlberg

Kristina Rennerstedt

Marie Nyreröd

Tom Österman, f d Bukowskis nu aktuell med bok om Ingmar Bergman-auktionen

Ulla Josephson Åberg

Ulrika Knutson

Yvonne Ekdahl

Agneta Pleijel

Alexander Erwik

Andreas T Olsson

Anna-Lotta Larsson

Berit Gullberg och Owe Thörnqvist

Björn Elgerd, skåd Stockholms Stadsteater

Camilla Lundberg

Heli Haspasslo, museichef Hallwylska museet

Håkan Lahger

Jan Holmberg, vd Stiftelsen Ingmar Bergman

Siv Wennberg

Karin Siden, museichef Valdemarsudde

Katinka Faragó

Katarina Strandmark

Markku Saarinen

Michael Porseryd, vd SF Studios

Lisa Ohlin

Rebecka Enhörning, chef Skokloster Slott

Stefan Larsson

Rojda Sekersöz, regissör (Dröm vidare och regisserar nu En komikers uppväxt)

Tanja Lorentzon

Staffan Carlén

Arrangment: Ingmar Bergman stiftelsen (Foundation)

Exhibition: Scenkonstmuseet

Invitation to celebrate the 100th anniversary of Ingmar Bergman's birth with us! On July 14, 1918…

[thatcreepyaesthetic]

Mumindalen 1973 (X) 

[ozu-teapot]

Fanny och Alexander (Fanny and Alexander) | Ingmar Bergman | 1982

The First Act: The Ekdahl Family Celebrates Christmas

Christina Schollin, Börje Ahlstedt